Literature DB >> 19380814

A proviral role for CpG in cytomegalovirus infection.

Ann-Charlotte Iversen1, Bjørg Steinkjer, Nadra Nilsen, Janne Bohnhorst, Siv Helen Moen, Randi Vik, Phil Stephens, David W Thomas, Chris A Benedict, Terje Espevik.   

Abstract

TLR9-dependent signaling in plasmacytoid dendritic cells is a key contributor to innate immune defense to mouse CMV infection. We aimed to study the expression and potential contribution of TLR9 signaling in human CMV (HCMV) infection of primary fibroblasts. HCMV infection strongly induced TLR9 expression in two of three fibroblast types tested. Furthermore, the TLR9 ligand CpG-B induced a strong proviral effect when added shortly after HCMV infection, enhancing virus production and cell viability. However, not all CpG classes displayed proviral activity, and this correlated with their IFN-beta-inducing ability. The proviral effect of CpG-B correlated completely with concurrent viral up-regulation of TLR9 in fibroblasts. Importantly, the timing of CpG addition was a critical parameter; in striking contrast to the proviral effect, CpG addition at the time of infection blocked viral uptake and nearly abolished HCMV production. The contrasting and time-dependent effects of CpG on HCMV infectivity reveal a complex interplay between CpG, TLR9, and HCMV infection. Additionally, the data suggest a potentially harmful role for CpG in the promotion of HCMV infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380814     DOI: 10.4049/jimmunol.0801268

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  UL26 Attenuates IKKβ-Mediated Induction of Interferon-Stimulated Gene (ISG) Expression and Enhanced Protein ISGylation during Human Cytomegalovirus Infection.

Authors:  Christopher M Goodwin; Xenia Schafer; Joshua Munger
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

2.  Artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication.

Authors:  Ran He; Kyoungsook Park; Hongyi Cai; Arun Kapoor; Michael Forman; Bryan Mott; Gary H Posner; Ravit Arav-Boger
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

3.  TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients.

Authors:  Chao Wang; Shouqiang Cao; Ying Yan; Qiao Ying; Tao Jiang; Ke Xu; Anhua Wu
Journal:  BMC Cancer       Date:  2010-08-10       Impact factor: 4.430

4.  IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control.

Authors:  Iulia Popescu; Matthew R Pipeling; Hannah Mannem; Pali D Shah; Jonathan B Orens; Mark Connors; Stephen A Migueles; John F McDyer
Journal:  J Immunol       Date:  2015-12-11       Impact factor: 5.422

Review 5.  Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship.

Authors:  Giada Rossini; Cristina Cerboni; Angela Santoni; Maria Paola Landini; Santo Landolfo; Deborah Gatti; Giorgio Gribaudo; Stefania Varani
Journal:  Mediators Inflamm       Date:  2012-05-31       Impact factor: 4.711

6.  Plasmacytoid dendritic cells and the control of herpesvirus infections.

Authors:  Thomas Baranek; Nicolas Zucchini; Marc Dalod
Journal:  Viruses       Date:  2009-10-14       Impact factor: 5.048

Review 7.  Viral enhancer mimicry of host innate-immune promoters.

Authors:  Kai A Kropp; Ana Angulo; Peter Ghazal
Journal:  PLoS Pathog       Date:  2014-02-06       Impact factor: 6.823

8.  A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection.

Authors:  Kai A Kropp; Wei Yuan Hsieh; Elena Isern; Thorsten Forster; Eva Krause; Wolfram Brune; Ana Angulo; Peter Ghazal
Journal:  PLoS Pathog       Date:  2015-04-09       Impact factor: 6.823

9.  TLR9 2848 GA heterozygotic status possibly predisposes fetuses and newborns to congenital infection with human cytomegalovirus.

Authors:  Wioletta Wujcicka; Edyta Paradowska; Mirosława Studzińska; Zuzanna Gaj; Jan Wilczyński; Zbigniew Leśnikowski; Dorota Nowakowska
Journal:  PLoS One       Date:  2015-04-06       Impact factor: 3.240

10.  Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes.

Authors:  Mark W Julian; Heather R Strange; Megan N Ballinger; Richard S Hotchkiss; Tracey L Papenfuss; Elliott D Crouser
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.